Quality Measure FHIR Update

Last year DHIT engaged in a Pilot with NCQA FHIR based Quality Measures. DHIT is collaborating with teams from Mitre, The Joint Commission, NCQA, CMS and other measure developers to ensure the roadblocks to the FHIR-based Quality Measure process are known and addressed.

We focused on the evaluation of EH measures 71, 104, and 506 and were able to successfully incorporate and test the latest versions of these measures. DHIT explored challenges involvingvolume of data and frequency of data element updates during a patient’s visit. The industry recognizes there are many challenges surrounding these aspects. We also incorporated the EP and EH measures listed in the list to the right into our FHIR server (see list). Our Team worked through testing these measures and shared our findings. We are eager to set more eCQMs on FHIR!

  • CMS 72 Ischemic stroke patients administered antithrombotic therapy by the end of hospital day 2
  • CMS 108 Venous Thromboembolism Prophylaxis
  • CMS 190 Intensive Care Unit Venous Thromboembolism Prophylaxis
  • CMS 334 Cesarean Birth
  • CMS 506 Safe Use of Opioids – Concurrent Prescribing
  • CMS 1028 Severe Obstetric Complications
  • CMS 2 Preventive care/screening: screening for clinical depression and follow up plan
  • CMS 50 Closing the referral loop: receipt of specialist report
  • CMS 68 Documentation of current medications in medical record
  • CMS 129 Prostate cancer: avoidance of overuse of bone scan for staging low risk prostate cancer patients
  • CMS 146 Appropriate Testing for Pharyngitis
  • CMS 177 Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
  • CMS 349 HIV Screening
  • CMS 819 Hospital Harm – Opioid-Related Adverse Events
  • CMS 996 Appropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department (ED)

FHIR® is the registered trademark of Health Level Seven International and is used with the permission of HL7. The use of these trademarks do not constitute a
product endorsement by HL7.